Maze Therapeutics, Inc. (MAZE)
25.03
+0.57
(+2.33%)
USD |
NASDAQ |
May 20, 16:00
25.03
0.00 (0.00%)
After-Hours: 20:00
Maze Therapeutics Free Cash Flow : -122.12M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LENZ Therapeutics, Inc. | -87.44M |
| CDT Equity, Inc. | -17.96M |
| Liminatus Pharma, Inc. | -11.99M |
| Oruka Therapeutics, Inc. | -91.19M |
| MapLight Therapeutics, Inc. | -164.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.11M |
| Cash from Investing (Quarterly) | 6.275M |
| Cash from Financing (Quarterly) | 42.36M |
| Free Cash Flow Per Share (Quarterly) | -0.7274 |
| Free Cash Flow to Equity (Quarterly) | -77.12M |
| Free Cash Flow to Firm (Quarterly) | -38.34M |
| Free Cash Flow Yield | -10.00% |